Latest Acquisition Lands AxoSim in the News
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX […]
Latest Acquisition Lands AxoSim in the News Read more
Benson Capital Partners Announces First Investment in AxoSim
BENSON CAPITAL PARTNERS ANNOUNCES FIRST INVESTMENT IN AXOSIM, INC. AxoSim, Inc, Provider of BrainSim™ and NerveSim™ Neurological Drug Discovery Platforms
Benson Capital Partners Announces First Investment in AxoSim Read more
AxoSim Announces the Award of over $870,000 in Federal Grants
–Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health awarded to AxoSim– –The
AxoSim Announces the Award of over $870,000 in Federal Grants Read more
AxoSim’s Article in Top 100 Neuroscience Paper Downloads of 2019
We are excited to announce that our paper, “Engineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip®
AxoSim’s Article in Top 100 Neuroscience Paper Downloads of 2019 Read more